PL3137094T3 - Leczenie i profilaktyka choroby alzheimera (ad) - Google Patents
Leczenie i profilaktyka choroby alzheimera (ad)Info
- Publication number
- PL3137094T3 PL3137094T3 PL15720060.1T PL15720060T PL3137094T3 PL 3137094 T3 PL3137094 T3 PL 3137094T3 PL 15720060 T PL15720060 T PL 15720060T PL 3137094 T3 PL3137094 T3 PL 3137094T3
- Authority
- PL
- Poland
- Prior art keywords
- alzheimer
- disease
- prevention
- treatment
- Prior art date
Links
- 208000024827 Alzheimer disease Diseases 0.000 title 1
- 230000002265 prevention Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
- A61K33/08—Oxides; Hydroxides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/42—Phosphorus; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Neurology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Dermatology (AREA)
- Psychiatry (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Compounds Of Alkaline-Earth Elements, Aluminum Or Rare-Earth Metals (AREA)
- Medicines Containing Plant Substances (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP14166355 | 2014-04-29 | ||
| EP14166388 | 2014-04-29 | ||
| PCT/EP2015/059341 WO2015165968A1 (en) | 2014-04-29 | 2015-04-29 | Treatment and prevention of alzheimer's disease (ad) |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3137094T3 true PL3137094T3 (pl) | 2023-03-13 |
Family
ID=53039897
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL15720060.1T PL3137094T3 (pl) | 2014-04-29 | 2015-04-29 | Leczenie i profilaktyka choroby alzheimera (ad) |
Country Status (12)
| Country | Link |
|---|---|
| US (3) | US11065273B2 (pl) |
| EP (2) | EP4209222A1 (pl) |
| JP (1) | JP2017515812A (pl) |
| KR (1) | KR102506460B1 (pl) |
| CN (1) | CN106659736A (pl) |
| AU (1) | AU2015254665A1 (pl) |
| CA (1) | CA2946931A1 (pl) |
| DK (1) | DK3137094T3 (pl) |
| FI (1) | FI3137094T3 (pl) |
| PL (1) | PL3137094T3 (pl) |
| PT (1) | PT3137094T (pl) |
| WO (1) | WO2015165968A1 (pl) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2015165966A1 (en) * | 2014-04-29 | 2015-11-05 | Affiris Ag | Treatment and prevention of alzheimer's disease (ad) |
| PL3137094T3 (pl) | 2014-04-29 | 2023-03-13 | Advantage Therapeutics, Inc. | Leczenie i profilaktyka choroby alzheimera (ad) |
| ES2953381T3 (es) * | 2014-04-29 | 2023-11-13 | Advantage Therapeutics Inc | Tratamiento y prevención de la enfermedad de Alzheimer (AD) |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU3440593A (en) | 1993-01-14 | 1994-08-15 | Nelson Arispe | Methods and compositions for blocking amyloid protein ion channels |
| TWI239847B (en) * | 1997-12-02 | 2005-09-21 | Elan Pharm Inc | N-terminal fragment of Abeta peptide and an adjuvant for preventing and treating amyloidogenic disease |
| US6743427B1 (en) | 1997-12-02 | 2004-06-01 | Neuralab Limited | Prevention and treatment of amyloidogenic disease |
| WO2003089460A1 (en) * | 2002-04-19 | 2003-10-30 | The Governing Council Of The University Of Toronto | Immunological methods and compositions for the treatment of alzheimer's disease |
| AT413946B (de) | 2004-07-13 | 2006-07-15 | Mattner Frank Dr | Impfstoff gegen die alzheimer-krankheit |
| WO2009105641A2 (en) | 2008-02-20 | 2009-08-27 | New York University | Preventing and treating amyloid-beta deposition by stimulation of innate immunity |
| AT506820B1 (de) | 2008-06-12 | 2011-07-15 | Affiris Forschungs Und Entwicklungs Gmbh | Vakzine gegen alzheimer-krankheit |
| AT506819B1 (de) | 2008-06-12 | 2011-06-15 | Affiris Forschungs Und Entwicklungs Gmbh | Vakzin zur behandlung von alzheimer-krankheit |
| EP2145898A1 (en) * | 2008-07-15 | 2010-01-20 | CHIESI FARMACEUTICI S.p.A. | Anti-amyloid immunogenic compositions, methods and uses |
| AU2011234656B2 (en) | 2010-03-29 | 2013-08-01 | Novartis Ag | Composition comprising the amyloid beta 1-6 peptide coupled to a virus-like particle and an adjuvant |
| GB201101331D0 (en) | 2011-01-26 | 2011-03-09 | Glaxosmithkline Biolog Sa | Compositions and uses |
| WO2015165966A1 (en) * | 2014-04-29 | 2015-11-05 | Affiris Ag | Treatment and prevention of alzheimer's disease (ad) |
| PL3137094T3 (pl) | 2014-04-29 | 2023-03-13 | Advantage Therapeutics, Inc. | Leczenie i profilaktyka choroby alzheimera (ad) |
| ES2953381T3 (es) | 2014-04-29 | 2023-11-13 | Advantage Therapeutics Inc | Tratamiento y prevención de la enfermedad de Alzheimer (AD) |
-
2015
- 2015-04-29 PL PL15720060.1T patent/PL3137094T3/pl unknown
- 2015-04-29 JP JP2016565334A patent/JP2017515812A/ja active Pending
- 2015-04-29 PT PT157200601T patent/PT3137094T/pt unknown
- 2015-04-29 KR KR1020167033324A patent/KR102506460B1/ko active Active
- 2015-04-29 FI FIEP15720060.1T patent/FI3137094T3/fi active
- 2015-04-29 CA CA2946931A patent/CA2946931A1/en not_active Abandoned
- 2015-04-29 DK DK15720060.1T patent/DK3137094T3/da active
- 2015-04-29 WO PCT/EP2015/059341 patent/WO2015165968A1/en not_active Ceased
- 2015-04-29 CN CN201580029850.7A patent/CN106659736A/zh active Pending
- 2015-04-29 US US15/307,246 patent/US11065273B2/en active Active
- 2015-04-29 EP EP22211552.9A patent/EP4209222A1/en active Pending
- 2015-04-29 AU AU2015254665A patent/AU2015254665A1/en not_active Abandoned
- 2015-04-29 EP EP15720060.1A patent/EP3137094B1/en active Active
-
2021
- 2021-07-08 US US17/370,615 patent/US11857568B2/en active Active
-
2023
- 2023-11-20 US US18/514,612 patent/US20240148782A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| DK3137094T3 (da) | 2023-02-27 |
| US11857568B2 (en) | 2024-01-02 |
| CA2946931A1 (en) | 2015-11-05 |
| EP4209222A1 (en) | 2023-07-12 |
| US20240148782A1 (en) | 2024-05-09 |
| KR20160145821A (ko) | 2016-12-20 |
| EP3137094B1 (en) | 2022-12-07 |
| CN106659736A (zh) | 2017-05-10 |
| US11065273B2 (en) | 2021-07-20 |
| PT3137094T (pt) | 2023-03-09 |
| JP2017515812A (ja) | 2017-06-15 |
| FI3137094T3 (fi) | 2023-03-20 |
| KR102506460B1 (ko) | 2023-03-03 |
| AU2015254665A1 (en) | 2016-11-10 |
| EP3137094A1 (en) | 2017-03-08 |
| US20220000908A1 (en) | 2022-01-06 |
| WO2015165968A1 (en) | 2015-11-05 |
| US20170049810A1 (en) | 2017-02-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL247085A0 (en) | Methods for treating Alzheimer's disease | |
| IL276315A (en) | Donepezil preparations and a method for treating Alzheimer's disease | |
| ZA201605341B (en) | Methods of treating alzheimer's disease | |
| IL266047A (en) | Methods and preparations for the treatment of Fabry disease | |
| EP3182989A4 (en) | Methods and compositions for the prevention and treatment of disease | |
| IL248592A0 (en) | Treatment of Crohn's disease using delayed-release 6-mercaptofurin | |
| EP3137097C0 (en) | TREATMENT AND PREVENTION OF ALZHEIMER | |
| IL248935A0 (en) | Diagnostic testing and treatment/prevention of Alzheimer's disease | |
| PT3458045T (pt) | Ebselen para uso no tratamento da doença de ménière | |
| PT3137094T (pt) | Tratamento e prevenção da doença de alzheimer (da) | |
| IL254252A0 (en) | History of Tetrahydrofuran-Oahe Aminohydrothiazine Usefulness in the Treatment of Alzheimer's Disease | |
| PL3352742T3 (pl) | Kompozycje zawierające triterpenoidy do leczenia choroby alzheimera i choroby parkinsona | |
| SG11201705889VA (en) | Prevention or Treatment of Uratic or Gouty Diseases | |
| PL3137093T3 (pl) | Leczenie i profilaktyka choroby Alzheimera (AD) | |
| IL251135A (en) | A method for the synthesis of hydroxy-triglycerides and their use for disease prevention and treatment | |
| ZA201801945B (en) | Compositions and methods for the treatment of parkinson's disease | |
| GB201511453D0 (en) | Treatment of alzheimer's disease | |
| GB201621398D0 (en) | Treatment of emt-associated disease | |
| GB201504144D0 (en) | Treatment of Parkinson's disease | |
| AU2015904411A0 (en) | Compositions and methods for the treatment of Alzheimer's disease | |
| GB201518052D0 (en) | Parkinson's disease treatment | |
| GB201610906D0 (en) | Treatment of cardiovascular disease | |
| GB201504413D0 (en) | Treatment of disease | |
| HK1230506A1 (en) | Treatment of crohn's disease with delayed-release 6-mercaptopurine |